In silico screening and in vitro validation of phytocompounds as multidrug efflux pump inhibitor against E. coli

References

• Alav, I., Sutton, J. M., & Rahman, K. M. (2018). Role of bacterial efflux pumps in biofilm formation. The Journal of Antimicrobial Chemotherapy, 73(8), 2003–2020. https://doi.org/10.1093/jac/dky042
   PubMed Web of Science ®Google Scholar
• Anes, J., McCusker, M. P., Fanning, S., & Martins, M. (2015). The ins and outs of RND efflux pumps in Escherichia coli. Frontiers in Microbiology, 6, 587. https://doi.org/10.3389/fmicb.2015.00587
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1-3), 43–56. https://doi.org/10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015). Molecular mechanisms of antibiotic resistance. Nature Reviews. Microbiology, 13(1), 42–51. https://doi.org/10.1038/nrmicro3380
   PubMed Web of Science ®Google Scholar
• Brogden, K. A. (2005). Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nature Reviews. Microbiology, 3(3), 238–250. https://doi.org/10.1038/nrmicro1098
   PubMed Web of Science ®Google Scholar
• Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. The Journal of Chemical Physics, 126(1), 014101. https://doi.org/10.1063/1.2408420
   PubMed Web of Science ®Google Scholar
• Chai, B., Jiang, W., Hu, M., Wu, Y., & Si, H. (2019). In vitro synergistic interactions of Protocatechuic acid and Chlorogenic acid in combination with antibiotics against animal pathogens. Synergy, 9, 100055. https://doi.org/10.1016/j.synres.2019.100055
   Google Scholar
• Chitsaz, M., & Brown, M. H. (2017). The role played by drug efflux pumps in bacterial multidrug resistance. Essays in Biochemistry, 61(1), 127–139. https://doi.org/10.1042/EBC20160064
   PubMed Web of Science ®Google Scholar
• Christaki, E., Marcou, M., & Tofarides, A. (2020). Antimicrobial resistance in bacteria: Mechanisms, evolution, and persistence. Journal of Molecular Evolution, 88(1), 26–40. https://doi.org/10.1007/s00239-019-09914-3
   PubMed Web of Science ®Google Scholar
• Ciulla, M. G., & Kumar, K. (2018). The natural and synthetic indole weaponry against bacteria. Tetrahedron Letters, 59(34), 3223–3233. https://doi.org/10.1016/j.tetlet.2018.07.045
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. (2017). Performance standards for antimicrobial susceptibility testing. CLSI supplement M100 (27th ed.). Clinical and Laboratory Standards Institute.
   Google Scholar
• Coldham, N. G., Webber, M., Woodward, M. J., & Piddock, L. J. V. (2010). A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli. Journal of Antimicrobial Chemotherapy, 65(8), 1655–1663. https://doi.org/10.1093/jac/dkq169
   PubMed Web of Science ®Google Scholar
• Costa, S., Junqueira, E., Palma, C., Viveiros, M., Melo-Cristino, J., Amaral, L., & Couto, I. (2013). Resistance to antimicrobials mediated by efflux pumps in Staphylococcus aureus. Antibiotics, 2(1), 83–99. https://doi.org/10.3390/antibiotics2010083
   Google Scholar
• Dreier, J., & Ruggerone, P. (2015). Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa. Frontiers in Microbiology, 6, 660. https://doi.org/10.3389/fmicb.2015.00660
   PubMed Web of Science ®Google Scholar
• Fernández-Cuenca, F., Tomás-Carmona, M., Caballero-Moyano, F., Bou, G., Martínez-Martínez, L., Vila, J., Pachón, J., Cisneros, J. M., Rodríguez-Baño, J., & Pascual, Á. (2013). In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: Multicenter national study GEIH-REIPI-Ab 2010. Enfermedades Infecciosas y Microbiologia Clinica, 31(1), 4-9. https://doi.org/10.1016/j.eimc.2012.06.010
   Google Scholar
• Fiamegos, Y. C., Kastritis, P. L., Exarchou, V., Han, H., Bonvin, A. M. J. J., Vervoort, J., Lewis, K., Hamblin, M. R., & Tegos, G. P. (2011). Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLoS One, 6(4), e18127. https://doi.org/10.1371/journal.pone.0018127
   PubMed Web of Science ®Google Scholar
• Fouedjou, R. T., Chtita, S., Bakhouch, M., Belaidi, S., Ouassaf, M., Djoumbissie, L. A., Tapondjou, L. A., & Abul Qais, F. (2021). Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/10.1080/07391102.2021.1914170
   Google Scholar
• Founou, R. C., Founou, L. L., & Essack, S. Y. (2017). Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PLoS One, 12(12), e0189621. https://doi.org/10.1371/journal.pone.0189621
   PubMed Web of Science ®Google Scholar
• Garvey, M. I., & Piddock, L. J. V. (2008). The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrobial Agents and Chemotherapy, 52(5), 1677–1685. https://doi.org/10.1128/AAC.01644-07
   PubMed Web of Science ®Google Scholar
• Hetényi, C., & van der Spoel, D. (2011). Toward prediction of functional protein pockets using blind docking and pocket search algorithms. Protein Science, 20(5), 880–893. https://doi.org/10.1002/pro.618
   PubMed Web of Science ®Google Scholar
• Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2016). Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet, 387(10014), 176–187. https://doi.org/10.1016/S0140-6736(15)00473-0
   PubMed Web of Science ®Google Scholar
• Hsu, J.-Y., Chuang, Y.-C., Wang, J.-T., Chen, Y.-C., & Hsieh, S.-M. (2021). Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017–2019. Journal of the Formosan Medical Association, 120(11), 1994–2002. https://doi.org/10.1016/j.jfma.2021.04.014
   PubMed Web of Science ®Google Scholar
• Jamshidi, S., Sutton, J. M., & Rahman, K. M. (2016). An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors. Future Medicinal Chemistry, 8(2), 195–210. https://doi.org/10.4155/fmc.15.173
   PubMed Web of Science ®Google Scholar
• Karunanidhi, A., Thomas, R., van Belkum, A., & Neela, V. (2013). In vitro antibacterial and antibiofilm activities of chlorogenic acid against clinical isolates of Stenotrophomonas maltophilia including the trimethoprim/sulfamethoxazole resistant strain. BioMed Research International, 2013, 1–7. https://doi.org/10.1155/2013/392058
   Web of Science ®Google Scholar
• Kumari, R., Kumar, R., Lynn, A., & Open Source Drug Discovery Consortium. (2014). g_mmpbsa – A GROMACS tool for high-throughput MM-PBSA calculations . Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lamut, A., Peterlin Mašič, L., Kikelj, D., & Tomašič, T. (2019). Efflux pump inhibitors of clinically relevant multidrug resistant bacteria. Medicinal Research Reviews, 39(6), 2460–2504. https://doi.org/10.1002/med.21591
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1-3), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0
   PubMed Web of Science ®Google Scholar
• Lou, Z., Wang, H., Zhu, S., Ma, C., & Wang, Z. (2011). Antibacterial activity and mechanism of action of chlorogenic acid. Journal of Food Science, 76(6), M398–M403. https://doi.org/10.1111/j.1750-3841.2011.02213.x
   PubMed Web of Science ®Google Scholar
• Maheshwari, M., Ahmad, I., & Althubiani, A. S. (2016). Multidrug resistance and transferability of blaCTX-M among extended-spectrum β-lactamase-producing enteric bacteria in biofilm. Journal of Global Antimicrobial Resistance, 6, 142–149. https://doi.org/10.1016/j.jgar.2016.04.009
   PubMed Web of Science ®Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Martinez, A. E., Widmer, A., Frei, R., Pargger, H., Tuchscherer, D., Marsch, S., Egli, A., & Tschudin-Sutter, S. (2019). ESBL-colonization at ICU admission: Impact on subsequent infection, carbapenem-consumption, and outcome. Infection Control and Hospital Epidemiology, 40(4), 408–413. https://doi.org/10.1017/ice.2019.5
   PubMed Web of Science ®Google Scholar
• Metzger, R. R., Brown, J. M., Sandoval, V., Rau, K. S., Elwan, M. A., Miller, G. W., Hanson, G. R., & Fleckenstein, A. E. (2002). Inhibitory effect of reserpine on dopamine transporter function. European Journal of Pharmacology, 456(1-3), 39–43. https://doi.org/10.1016/S0014-2999(02)02647-X
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Musa, M. A., Cooperwood, J. S., Khan, M. O. F., & Rahman, T. (2011). In-vitro antiproliferative activity of benzopyranone derivatives in comparison with standard chemotherapeutic drugs. Archiv Der Pharmazie, 344(2), 102–110. https://doi.org/10.1002/ardp.201000207
   PubMed Web of Science ®Google Scholar
• Nabekura, T., Kamiyama, S., & Kitagawa, S. (2005). Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochemical and Biophysical Research Communications, 327(3), 866–870. https://doi.org/10.1016/j.bbrc.2004.12.081
   PubMed Web of Science ®Google Scholar
• Navia, M., & Chaturvedi, P. (1996). Design principles for orally bioavailable drugs. Drug Discovery Today, 1(5), 179–189. https://doi.org/10.1016/1359-6446(96)10020-9
   Web of Science ®Google Scholar
• Naylor, N. R., Atun, R., Zhu, N., Kulasabanathan, K., Silva, S., Chatterjee, A., Knight, G. M., & Robotham, J. V. (2018). Estimating the burden of antimicrobial resistance: A systematic literature review. Antimicrobial Resistance and Infection Control, 7(1), 58. https://doi.org/10.1186/s13756-018-0336-y
   PubMedGoogle Scholar
• Negi, N. (2014). Possible role of curcumin as ection an efflux pump inhibitor in multi drug resistant clinical isolates of Pseudomonas aeruginosa. Journal of Clinical and Diagnostic Research, 8(10), 04. https://doi.org/10.7860/JCDR/2014/8329.4965
   Google Scholar
• Neuberger, A., Du, D., & Luisi, B. F. (2018). Structure and mechanism of bacterial tripartite efflux pumps. Research in Microbiology, 169(7-8), 401–413. https://doi.org/10.1016/j.resmic.2018.05.003
   PubMed Web of Science ®Google Scholar
• Nikaido, H. (1998). Multiple antibiotic resistance and efflux. Current Opinion in Microbiology, 1(5), 516–523. https://doi.org/10.1016/S1369-5274(98)80083-0
   PubMed Web of Science ®Google Scholar
• Ohene-Agyei, T., Lea, J. D., & Venter, H. (2012). Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets. FEMS Microbiology Letters, 333(1), 20–27. https://doi.org/10.1111/j.1574-6968.2012.02594.x
   PubMed Web of Science ®Google Scholar
• Opperman, T. J., Kwasny, S. M., Kim, H.-S., Nguyen, S. T., Houseweart, C., D'Souza, S., Walker, G. C., Peet, N. P., Nikaido, H., & Bowlin, T. L. (2014). Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli. Antimicrobial Agents and Chemotherapy, 58(2), 722–733. https://doi.org/10.1128/AAC.01866-13
   PubMed Web of Science ®Google Scholar
• Pal, S., Kumar, V., Kundu, B., Bhattacharya, D., Preethy, N., Reddy, M. P., & Talukdar, A. (2019). Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors. Computational and Structural Biotechnology Journal, 17, 291–310. https://doi.org/10.1016/j.csbj.2019.02.006
   PubMed Web of Science ®Google Scholar
• Parai, D., Banerjee, M., Dey, P., & Mukherjee, S. K. (2020). Reserpine attenuates biofilm formation and virulence of Staphylococcus aureus. Microbial Pathogenesis, 138, 103790. https://doi.org/10.1016/j.micpath.2019.103790
   PubMed Web of Science ®Google Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/10.1063/1.328693
   Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera – A visualization system for exploratory research and analysis . Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Pfeifer, H. J., Greenblatt, D. K., & Koch-Wester, J. (1976). Clinical toxicity of reserpine in hospitalized patients: A report from the Boston Collaborative Drug Surveillance Program. The American Journal of the Medical Sciences, 271(3), 269–276. https://doi.org/10.1097/00000441-197605000-00002
   PubMed Web of Science ®Google Scholar
• Prasch, S., & Bucar, F. (2015). Plant derived inhibitors of bacterial efflux pumps: An update. Phytochemistry Reviews, 14(6), 961–974. https://doi.org/10.1007/s11101-015-9436-y
   Web of Science ®Google Scholar
• Rath, B., Abul Qais, F., Patro, R., Mohapatra, S., & Sharma, T. (2021). Design, synthesis and molecular modeling studies of novel mesalamine linked coumarin for treatment of inflammatory bowel disease. Bioorganic & Medicinal Chemistry Letters, 41, 128029. https://doi.org/10.1016/j.bmcl.2021.128029
   PubMed Web of Science ®Google Scholar
• Schaduangrat, N., Lampa, S., Simeon, S., Gleeson, M. P., Spjuth, O., & Nantasenamat, C. (2020). Towards reproducible computational drug discovery. Journal of Cheminformatics, 12(1), 9. https://doi.org/10.1186/s13321-020-0408-x
   PubMed Web of Science ®Google Scholar
• Shin, J., Prabhakaran, V.-S., & Kim, K. (2018). The multi-faceted potential of plant-derived metabolites as antimicrobial agents against multidrug-resistant pathogens. Microbial Pathogenesis, 116, 209–214. https://doi.org/10.1016/j.micpath.2018.01.043
   PubMed Web of Science ®Google Scholar
• Shriram, V., Khare, T., Bhagwat, R., Shukla, R., & Kumar, V. (2018). Inhibiting bacterial drug efflux pumps via phyto-therapeutics to combat threatening antimicrobial resistance. Frontiers in Microbiology, 9, 2990. https://doi.org/10.3389/fmicb.2018.02990
   PubMed Web of Science ®Google Scholar
• Siddiqui, S., Ameen, F., Jahan, I., Nayeem, S. M., & Tabish, M. (2019). A comprehensive spectroscopic and computational investigation on the binding of the anti-asthmatic drug triamcinolone with serum albumin. New Journal of Chemistry, 43(10), 4137–4151. https://doi.org/10.1039/C8NJ05486J
   Web of Science ®Google Scholar
• Siddiqui, S., Ameen, F., Kausar, T., Nayeem, S. M., Ur Rehman, S., & Tabish, M. (2021). Biophysical insight into the binding mechanism of doxofylline to bovine serum albumin: An in vitro and in silico approach. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 249, 119296. https://doi.org/10.1016/j.saa.2020.119296
   PubMed Web of Science ®Google Scholar
• Sousa Da Silva, A. W., & Vranken, W. F. (2012). ACPYPE – AnteChamber PYthon Parser interfacE. BMC Research Notes, 5, 367. https://doi.org/10.1186/1756-0500-5-367
   PubMedGoogle Scholar
• Spengler, G., Kincses, A., Gajdács, M., & Amaral, L. (2017). New roads leading to old destinations: Efflux pumps as targets to reverse multidrug resistance in bacteria. Molecules, 22(3), 468. https://doi.org/10.3390/molecules22030468
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455-461. https://doi.org/10.1002/jcc.21334
   Web of Science ®Google Scholar
• Verma, P., Tiwari, M., & Tiwari, V. (2021). Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors. Microbial Pathogenesis, 152, 104766. https://doi.org/10.1016/j.micpath.2021.104766
   PubMed Web of Science ®Google Scholar
• Watanabe, T., Arai, Y., Mitsui, Y., Kusaura, T., Okawa, W., Kajihara, Y., & Saito, I. (2006). The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clinical and Experimental Hypertension, 28(5), 439–449. https://doi.org/10.1080/10641960600798655
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2017). Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. Essential Medicines and Health Products. WHO reference number: WHO/EMP/IAU/2017.12.
   Google Scholar
• Zhang, Y., Wei, J., Qiu, Y., Niu, C., Song, Z., Yuan, Y., & Yue, T. (2019). Structure-dependent inhibition of Stenotrophomonas maltophilia by polyphenol and its impact on cell membrane. Frontiers in Microbiology, 10, 2646. https://doi.org/10.3389/fmicb.2019.02646
   PubMed Web of Science ®Google Scholar